GlobeNewswire: MPX Bioceutical Corporation Contains the last 10 of 71 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T08:41:15ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2019/01/18/1702593/0/en/MPX-Receives-Final-Court-Approval-for-Arrangement-with-iAnthus.html?f=22&fvtc=4&fvtv=49118MPX Receives Final Court Approval for Arrangement with iAnthus2019-01-18T22:00:00Z<![CDATA[NEW YORK and TORONTO, Jan. 18, 2019 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”), (CSE: IAN, OTCQB: ITHUF) and MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC: MPXEF) are pleased to announce that the Supreme Court of British Columbia has issued a final order approving the previously announced plan of arrangement (the “Arrangement”) under the Business Corporations Act (British Columbia) pursuant to which iAnthus will acquire all of the issued and outstanding common shares of MPX pursuant to the terms of an Arrangement Agreement between iAnthus and MPX dated October 18, 2018 (the “Arrangement Agreement”).]]>https://www.globenewswire.com/news-release/2019/01/15/1696458/0/en/MPX-Securityholders-Overwhelming-Approve-Transformational-Business-Combination-with-iAnthus.html?f=22&fvtc=4&fvtv=49118MPX Securityholders Overwhelming Approve Transformational Business Combination with iAnthus2019-01-15T23:00:00Z<![CDATA[NEW YORK and TORONTO, Jan. 15, 2019 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”), (CSE: IAN, OTCQB: ITHUF) and MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC: MPXEF) are pleased to announce that at the special meeting of MPX securityholders (“MPX Securityholders”) held today, (the “Meeting”), MPX Securityholders voted overwhelmingly in favour of a special resolution (the “Arrangement Resolution”) to approve the previously announced plan of arrangement (the “Arrangement”) under the Business Corporations Act (British Columbia) between iAnthus and MPX whereby iAnthus will acquire all of the issued and outstanding common shares (the “MPX Shares”) of MPX pursuant to the terms of an Arrangement Agreement between iAnthus and MPX dated October 18, 2018 (the “Arrangement Agreement”). Obtaining approval from the MPX Securityholders is one of the primary conditions to completing the Arrangement.]]>https://www.globenewswire.com/news-release/2019/01/03/1680433/0/en/MPX-Announces-Acquisition-of-Remaining-Interests-in-Massachusetts-Companies.html?f=22&fvtc=4&fvtv=49118MPX Announces Acquisition of Remaining Interests in Massachusetts Companies2019-01-03T22:00:00Z<![CDATA[TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC: MPXEF) announced that on December 28, 2018, it had agreed to acquire certain minority interests in two Massachusetts entities associated with certain cultivation and production activities. The entities include IMT, LLC and Fall River Development Co. LLC, both limited liability companies domesticated in Massachusetts (“Sellers”). Through its wholly-owned subsidiary CGX Life Sciences Inc. of Nevada, MPX currently owns fifty-one percent (51.0%) of each entity, and today announces its agreement to acquire the remaining interests in an all-stock transaction.]]>https://www.globenewswire.com/news-release/2019/01/03/1680124/0/en/ISS-and-Glass-Lewis-Recommend-MPX-Securityholders-Vote-in-Favour-of-the-Arrangement-and-MPX-Shareholders-Vote-in-Favour-of-the-MPX-Continuance-and-the-MPX-International-Stock-Optio.html?f=22&fvtc=4&fvtv=49118ISS and Glass Lewis Recommend MPX Securityholders Vote in Favour of the Arrangement and MPX Shareholders Vote in Favour of the MPX Continuance and the MPX International Stock Option Plan2019-01-03T13:30:00Z<![CDATA[TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (CSE: MPX) (OTC:MPXEF) (the “Company” or “MPX”) is pleased to announce that Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis and Co., LLC (“Glass Lewis”), two leading proxy advisory firms, have recommended that securityholders of MPX vote in favour of the proposed transaction (the “Arrangement”) whereby iAnthus Capital Holdings, Inc. (“iAnthus”), will acquire all of the issued and outstanding common shares of MPX through a court approved plan of arrangement under the Business Corporations Act (British Columbia) (“BCBCA”).]]>https://www.globenewswire.com/news-release/2018/12/12/1665938/0/en/iAnthus-and-MPX-Announce-Receipt-of-Interim-Court-Order.html?f=22&fvtc=4&fvtv=49118iAnthus and MPX Announce Receipt of Interim Court Order2018-12-12T13:56:04Z<![CDATA[NEW YORK and TORONTO, Dec. 12, 2018 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or “the Company”), (CSE: IAN, OTCQB: ITHUF) and MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC:MPXEF) announced today that on December 10, 2018, MPX was granted an interim order from the Supreme Court of British Columbia authorizing various matters, including the holding of a special meeting (the “Meeting”) of MPX securityholders (“MPX Securityholders”) to consider the previously announced arrangement among, inter alia, iAnthus and MPX (the “Arrangement”) whereby iAnthus intends to acquire all of the issued and outstanding common shares (the “MPX Shares”) of MPX (the “Transaction”) and the mailing of a management information circular (the “Circular”). Under the terms of the Arrangement, MPX Shareholders will receive 0.1673 of a common share of iAnthus (the “iAnthus Common Shares”) and 0.1 of a common share of MPX International for each MPX Share held.]]>https://www.globenewswire.com/news-release/2018/12/10/1664410/0/en/MPX-Awarded-Four-Conditional-Retail-Dispensary-Licenses-in-Nevada.html?f=22&fvtc=4&fvtv=49118MPX Awarded Four Conditional Retail Dispensary Licenses in Nevada2018-12-10T13:41:15Z<![CDATA[TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC: MPXEF) announced that GreenMart NLV, LLC (“GreenMart NLV”), a subsidiary of MPX, has been awarded four conditional retail marijuana store licenses in the state of Nevada.]]>https://www.globenewswire.com/news-release/2018/11/29/1659685/0/en/MPX-Reports-Financial-Results-for-Its-Fiscal-Second-Quarter-of-2019.html?f=22&fvtc=4&fvtv=49118MPX Reports Financial Results for Its Fiscal Second Quarter of 20192018-11-29T21:30:00Z<![CDATA[Quarterly Revenues increased 233% to $14.7 Million Quarterly Revenues increased 233% to $14.7 Million]]>https://www.globenewswire.com/news-release/2018/10/29/1638733/0/en/MPX-Expands-Maryland-Footprint-With-Opening-of-Health-for-Life-White-Marsh-Dispensary.html?f=22&fvtc=4&fvtv=49118MPX Expands Maryland Footprint With Opening of Health for Life White Marsh Dispensary2018-10-29T20:45:31Z<![CDATA[TORONTO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC: MPXEF) announced that the Company will open a new Health for Life dispensary in Nottingham, Maryland which is located at 4741 Ridge Rd, Nottingham, Maryland, 21236. The dispensary is operated by MPX’s indirect wholly-owned subsidiary, S8 Management LLC, through a management agreement with LMS Wellness, Benefit LLC (“LMS”), which provides all management services typically required by a dispensary facility to successfully operate. This is the Company’s third dispensary in Maryland, following the opening of its flagship Health for Life dispensary in Bethesda, in August 2018 and Health for Life dispensary in Baltimore, in October 2018.]]>Interior photo of the White Marsh Dispensary White Marsh Dispensaryhttps://www.globenewswire.com/news-release/2018/10/18/1623508/0/en/iAnthus-and-MPX-Bioceutical-Announce-Transformational-Combination-Expands-U-S-Footprint-to-10-States.html?f=22&fvtc=4&fvtv=49118iAnthus and MPX Bioceutical Announce Transformational Combination, Expands U.S. Footprint to 10 States2018-10-18T13:51:24Z<![CDATA[NEW YORK and TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”), (CSE: IAN, OTCQX: ITHUF), and MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC:MPXEF) announced today that both companies have signed an arrangement agreement (the “Agreement”) pursuant to which iAnthus will combine with MPX in an all-stock transaction with offered equity consideration to MPX shareholders valued at $835 million before giving effect to MPX International (defined below) and assuming all of MPX’s dilutive securities are exercised prior to the completion of the transaction. The Agreement represents the first public to public merger transaction in U.S. cannabis history.]]>https://www.globenewswire.com/news-release/2018/10/12/1620531/0/en/MPX-Expands-Maryland-Footprint-With-Opening-of-Baltimore-Dispensary.html?f=22&fvtc=4&fvtv=49118MPX Expands Maryland Footprint With Opening of Baltimore Dispensary2018-10-12T12:30:00Z<![CDATA[TORONTO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC: MPXEF) today announced that it opened its new Health for Life dispensary in Baltimore, Maryland which is located at 6807 Rolling Mill Rd Baltimore, Maryland 21224. The dispensay is operated by MPX’s indirect wholly-owned subsidiary, S8 Management LLC, through its management agreement with GreenMart of Maryland, LLC (“GreenMart MD”), which is authorized to operate and sell medical cannabis products in Maryland. This is the Company’s second dispensary in Maryland, following the opening of its flagship Health for Life dispensary in Bethesda, in August 2018. Health for Life Baltimore is open to patients Sunday through Saturday. Operating hours can be found in the Health for Life website.]]>Health for Life Baltimore DispensaryHealth for Life Baltimore Dispensary